The social discussions express general support for the article's findings, especially through posts about patients experiencing financial and emotional consequences, using words like 'regularly hear' and 'legal action' to emphasize real-world impacts. The tone reflects concern and a call for better patient warnings, showing moderate engagement and perceived impact on awareness.
AgreementStrong agreement
Most discussions support the findings, with posters acknowledging the link between dopamine agonists and impulse control issues, especially highlighting personal experiences and concerns about lack of warning from doctors.
InterestModerate interest
Posts show moderate interest, emphasizing real-world impacts like gambling losses and legal actions, suggesting concern but not deep scientific engagement.
EngagementModerate engagement
Participants involve themselves by sharing personal stories and calling for regulatory or medical action, indicating a reasonable level of engagement, though not highly technical.
ImpactModerate impact
The discussions likely raise awareness about medication risks and influence public perception, yet their overall influence on policy or clinical practice remains moderate.
Abstract in brief
Dopamine agonists (DAAs) are linked to impulse control disorders (ICDs), with prevalence rates ranging from 26% to 34.8% in Parkinson's disease patients, but lower rates in restless legs syndrome, and limited data for prolactinoma.
Key factors increasing the risk of ICDs include the specific type and dose of DAA, male gender, younger age, psychiatric history, earlier disease onset, longer disease duration, and motor complications in Parkinson's patients.
While guidelines exist to prevent and manage ICDs associated with DAA treatment, more research is needed to better identify patients who are most at risk.
Ropinirole, Pramipexole & Neupro can cause Impulse Control Disorder (ICD) in many patients. We regularly hear from members' who have lost money gambling or impulse spending. Legal action should be considered if your doctor failed to warn you of ICD.
https://t.co/9LpzwuKwua
Aug 6, 2024 · 2 likes · 2 shares · 1,010 followersView post →
JG
Julie Gould
@GrumpyoldGould · X
RT @RestlessLegsUK: Ropinirole, Pramipexole & Neupro can cause Impulse Control Disorder (ICD) in many patients. We regularly hear from memb…
Aug 6, 2024 · 2 shares · 1,932 followersView post →
MG
Megan Elizabeth Graham
@grahamemegan · X
Dopamine Agonists and Impulse Control Disorders: A Complex Association | SpringerLink https://t.co/mp4X2FEcwT
This episode covers outpatient low-dose initiation of buprenorphine for individuals using fentanyl, discussing effective strategies and recent research on safety and efficacy, along with insights into impulse control…
This episode discusses outpatient low-dose initiation of buprenorphine for fentanyl users, highlighting recent research and treatment strategies, including nonopioid pain management options and impulse control…
Ropinirole, Pramipexole & Neupro can cause Impulse Control Disorder (ICD) in many patients. We regularly hear from members' who have lost money gambling or impulse spending. Legal action should be considered if your doctor failed to warn you of ICD.
https://t.co/9LpzwuKwua
Aug 6, 2024 · 2 likes · 2 shares · 1,010 followersView post →
Sن
Sabrina G ن
@Sabb26 · X
Dopamine Agonists and Impulse Control Disorders: A Complex Association https://t.co/yogXVCHqCy
https://link.springer. com/article/10.1007/s40264-017-0590-6 FDA: FDA Approves Novel Non-Opioid Treatment for Moderate to Severe Acute Pain https://www.fda ...